LOGO.jpg
Interpace Biosciences’ Audit Committee Investigation Finds Complaints Unsubstantiated
14 oct. 2020 06h30 HE | Interpace Biosciences, Inc.
PARSIPPANY, NJ, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (Nasdaq: IDXG) announced today that the Audit Committee of the Board of Directors has...